Review articlePublished 28 Apr 2023
In osteoporotic ovariectomized rats, bone-targeting PLGA-derived lipid treatment delivery system decreases bone loss
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The distribution of anti-osteoporotic medications at the right dose has proven difficult due to the lack of safety, efficacy, and specificity. In our research, bone-specific polyaspartic acid Asp) 8-DNPs were added to cathepsin K inhibitor loaded poly derived lipid hybrid nanoparticles to cure osteoporosis. DNPs shown their affinity for binding to hydroxyapatite and were successful in releasing cathepsin K inhibitors over the course of up to 5 days. The tartrate-resistant acid phosphatase activity and resorption-related genes in osteoclasts were drastically reduced by cathepsin K inhibitor loaded Asp 8-DNPs. The tibia and femur of animals showed high levels of Asp 8-DNP accumulation, as well as increased trabecular bone mass and more organised three-dimensional architecture in osteoporotic rat models. Herein, the bone targeted drug delivery system show its potential in treatment of osteoporosis Keywords Bone-targeting; Polyaspartic acid peptides; Drug delivery system; Osteoporosis; Anti-osteoporosis drug
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMolecular Enzymology and Drug Targets
- SubjectBiochemistry & Biotechnology
- SubjectGenetics & Molecular Biology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Shashi Singh”
